Needham & Company LLC Comments on Teleflex FY2025 Earnings

Teleflex Incorporated (NYSE:TFX) – Analysts at Needham & Company LLC dropped their FY2025 earnings per share estimates for Teleflex in a report issued on Tuesday, January 27th. Needham & Company LLC analyst M. Matson now forecasts that the medical technology company will post earnings of $13.96 per share for the year, down from their previous estimate of $14.11. Needham & Company LLC has a “Buy” rating and a $138.00 price target on the stock. The consensus estimate for Teleflex’s current full-year earnings is $13.98 per share.

A number of other analysts have also recently weighed in on TFX. Wells Fargo & Company dropped their target price on shares of Teleflex from $139.00 to $116.00 and set an “equal weight” rating on the stock in a report on Thursday. Royal Bank Of Canada reiterated a “sector perform” rating and set a $135.00 price objective on shares of Teleflex in a research note on Wednesday, December 17th. Wall Street Zen cut shares of Teleflex from a “buy” rating to a “hold” rating in a report on Saturday, November 15th. Truist Financial lifted their target price on Teleflex from $120.00 to $135.00 and gave the company a “hold” rating in a research note on Thursday, December 18th. Finally, Weiss Ratings reiterated a “sell (d)” rating on shares of Teleflex in a research report on Monday, December 29th. Two analysts have rated the stock with a Buy rating, eight have issued a Hold rating and two have issued a Sell rating to the company. Based on data from MarketBeat, Teleflex currently has a consensus rating of “Hold” and a consensus price target of $139.00.

Teleflex Price Performance

Teleflex stock opened at $104.40 on Friday. The firm has a market capitalization of $4.61 billion, a PE ratio of -14.20, a P/E/G ratio of 1.38 and a beta of 0.93. The firm’s 50-day simple moving average is $116.10 and its 200 day simple moving average is $119.60. The company has a quick ratio of 1.53, a current ratio of 2.57 and a debt-to-equity ratio of 0.67. Teleflex has a 52 week low of $100.18 and a 52 week high of $184.34.

Teleflex (NYSE:TFX) last posted its earnings results on Thursday, November 6th. The medical technology company reported $3.67 earnings per share for the quarter, beating the consensus estimate of $3.38 by $0.29. Teleflex had a positive return on equity of 15.64% and a negative net margin of 10.28%.The company had revenue of $892.90 million for the quarter, compared to analyst estimates of $892.79 million. During the same quarter in the prior year, the company earned $3.49 earnings per share. Teleflex’s revenue was up 19.4% compared to the same quarter last year. Teleflex has set its FY 2025 guidance at 14.000-14.200 EPS.

Institutional Inflows and Outflows

A number of institutional investors have recently added to or reduced their stakes in TFX. MassMutual Private Wealth & Trust FSB increased its holdings in shares of Teleflex by 57.9% during the third quarter. MassMutual Private Wealth & Trust FSB now owns 210 shares of the medical technology company’s stock valued at $26,000 after purchasing an additional 77 shares during the period. Hantz Financial Services Inc. increased its stake in Teleflex by 248.8% during the 3rd quarter. Hantz Financial Services Inc. now owns 279 shares of the medical technology company’s stock valued at $34,000 after buying an additional 199 shares during the period. Mirae Asset Global Investments Co. Ltd. acquired a new position in Teleflex during the 3rd quarter valued at about $35,000. V Square Quantitative Management LLC bought a new stake in shares of Teleflex during the 4th quarter worth about $37,000. Finally, Quent Capital LLC acquired a new stake in shares of Teleflex in the 3rd quarter worth approximately $38,000. Institutional investors and hedge funds own 95.62% of the company’s stock.

Teleflex Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Monday, December 15th. Investors of record on Friday, November 14th were issued a $0.34 dividend. This represents a $1.36 dividend on an annualized basis and a yield of 1.3%. The ex-dividend date of this dividend was Friday, November 14th. Teleflex’s dividend payout ratio is -18.50%.

About Teleflex

Teleflex Incorporated is a diversified global provider of medical technologies, specializing in critical care and surgery. Headquartered in Wayne, Pennsylvania, the company designs, manufactures and distributes devices and solutions used by healthcare professionals in hospital, ambulatory and alternate site settings. Teleflex focuses on delivering products that support complex interventional procedures and improve patient outcomes.

The company’s offerings span several key segments, including Interventional Urology, Respiratory & Anesthesia, Surgical, Cardiac Care, Vascular and Original Equipment Manufacturer (OEM) solutions.